Porton Down Science Park
Wiltshire
SP4 0JQ
GW is developing a portfolio of cannabinoid medicines, of which the lead product is Sativex, an oromucosal spray for the treatment of MS symptoms, cancer pain and neuropathic pain.
Description | Report Date | Published |
---|---|---|
Annual Report 2013 | 30-09-2013 | 06-12-2013 |
Annual Report 2012 | 30-06-2012 | 27-11-2012 |
Annual Report 2011 | 30-09-2011 | 21-11-2011 |
Annual Report 2010 | 30-09-2010 | 22-11-2010 |
Description | Report Date | Published |
---|---|---|
Interim Report 2014 | 31-03-2014 | 07-05-2014 |
Interim Report 2013 | 31-03-2013 | 14-05-2013 |
Interim Report 2012 | 31-03-2012 | 22-05-2012 |
Interim Report 2011 | 31-03-2011 | 17-05-2011 |
Description |
---|
Site Map |
Presentations |
Home |
Results Index |
Press Releases |
Contacts |
Type | Dividend | Payment Date |
---|---|---|
Nil | 0.0000 | 01-01-1970 |